REDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Thursday reported a loss of $28 million in its second quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 91 cents.
The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.
The maker of an electrical implant that treats leg and back pain posted revenue of $93.6 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $88 million.
Nevro expects full-year revenue in the range of $368 million to $374 million.
Nevro shares have increased 63% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $63.34, increasing slightly in the last 12 months.